Erin Mullane

580 total citations
15 papers, 298 citations indexed

About

Erin Mullane is a scholar working on Oncology, Electrical and Electronic Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erin Mullane has authored 15 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 4 papers in Electrical and Electronic Engineering and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erin Mullane's work include CAR-T cell therapy research (15 papers), Cancer-related cognitive impairment studies (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Erin Mullane is often cited by papers focused on CAR-T cell therapy research (15 papers), Cancer-related cognitive impairment studies (3 papers) and Biosimilars and Bioanalytical Methods (3 papers). Erin Mullane collaborates with scholars based in United States, South Africa and Brazil. Erin Mullane's co-authors include Cameron J. Turtle, David G. Maloney, Jenna Voutsinas, Merav Bar, Qian Wu, Jordan Gauthier, Krishna R. Juluri, Vicky Wu, Jue Hou and Jesse R. Fann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Erin Mullane

13 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Mullane United States 7 270 70 65 57 55 15 298
Xia Han United States 4 269 1.0× 69 1.0× 64 1.0× 64 1.1× 60 1.1× 8 312
Sandra B. Horowitz United States 9 227 0.8× 40 0.6× 49 0.8× 65 1.1× 33 0.6× 14 305
Ana Alarcón Tomás United States 8 177 0.7× 38 0.5× 52 0.8× 42 0.7× 47 0.9× 22 233
Claudia Diamonte United States 10 322 1.2× 108 1.5× 84 1.3× 79 1.4× 47 0.9× 18 353
Francesca Alt Germany 6 153 0.6× 46 0.7× 46 0.7× 42 0.7× 29 0.5× 12 257
Monalisa Ghosh United States 9 170 0.6× 26 0.4× 56 0.9× 63 1.1× 49 0.9× 45 308
Marion Subklewe Germany 10 212 0.8× 40 0.6× 35 0.5× 65 1.1× 37 0.7× 24 257
Miriam Sánchez‐Escamilla Spain 5 193 0.7× 72 1.0× 50 0.8× 66 1.2× 25 0.5× 13 239
Jean‐Marc Hoffmann Germany 9 248 0.9× 86 1.2× 63 1.0× 103 1.8× 24 0.4× 20 311
Vipul Sheth United States 7 184 0.7× 50 0.7× 44 0.7× 84 1.5× 22 0.4× 22 273

Countries citing papers authored by Erin Mullane

Since Specialization
Citations

This map shows the geographic impact of Erin Mullane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Mullane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Mullane more than expected).

Fields of papers citing papers by Erin Mullane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Mullane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Mullane. The network helps show where Erin Mullane may publish in the future.

Co-authorship network of co-authors of Erin Mullane

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Mullane. A scholar is included among the top collaborators of Erin Mullane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Mullane. Erin Mullane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Iovino, Lorenzo, Qian Wu, Jenna Voutsinas, et al.. (2022). Predictors of response to axicabtagene‐ciloleucel CAR T cells in aggressive B cell lymphomas: A real‐world study. Journal of Cellular and Molecular Medicine. 26(24). 5976–5983. 9 indexed citations
2.
Wu, Qian, Jenna Voutsinas, Erin Mullane, et al.. (2022). Predictors of cytopenias after treatment with axicabtagene ciloleucel in patients with large B-cell lymphoma. Leukemia & lymphoma. 63(12). 2918–2922. 1 indexed citations
3.
Crombie, Jennifer L., Robert Redd, Victor A. Chow, et al.. (2021). Prognostic Value of Early PET in Patients with Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 CAR T-Cell Therapy. Blood. 138(Supplement 1). 886–886. 2 indexed citations
4.
Juluri, Krishna R., Qian Wu, Jenna Voutsinas, et al.. (2021). Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy. Blood Advances. 6(7). 2055–2068. 85 indexed citations
5.
Mullane, Erin, Jenna Voutsinas, Qian Wu, et al.. (2020). Patient-Reported Outcomes at Time of CAR-T Cell Therapy. Blood. 136(Supplement 1). 35–36. 4 indexed citations
6.
Perkins, Paula, et al.. (2020). Assessing readmission after axicabtagene ciloleucel immunotherapy.. Journal of Clinical Oncology. 38(15_suppl). 3024–3024.
7.
Juluri, Krishna R., Alexandre V. Hirayama, Erin Mullane, et al.. (2020). Factors Associated with Impaired Hematopoietic Recovery after CD19-Targeted CAR-T Cell Therapy. Biology of Blood and Marrow Transplantation. 26(3). S313–S313. 3 indexed citations
8.
Gauthier, Jordan, Paula Perkins, Jenna Voutsinas, et al.. (2020). Predictors of Cytopenia after Treatment with Axicabtagene Ciloleucel in Patients with Large Cell Lymphoma. Blood. 136(Supplement 1). 1–2. 3 indexed citations
9.
Mullane, Erin, Ana Cordeiro, Evandro D. Bezerra, et al.. (2019). Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy. Biology of Blood and Marrow Transplantation. 26(1). 34–43. 108 indexed citations
10.
Juluri, Krishna R., Alexandre V. Hirayama, Erin Mullane, et al.. (2019). Severe Cytokine Release Syndrome Is Associated with Impaired Hematopoietic Recovery after CD19-Targeted CAR-T Cell Therapy. Blood. 134(Supplement_1). 3229–3229. 2 indexed citations
12.
Bar, Merav, Erin Mullane, Ana Cordeiro, et al.. (2019). Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy. Blood. 134(Supplement_1). 4453–4453.
13.
Chow, Victor A., Ajay K. Gopal, David G. Maloney, et al.. (2018). Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy. Blood. 132(Supplement 1). 94–94. 13 indexed citations
14.
Specht, Jennifer M., Sylvia Lee, Cameron J. Turtle, et al.. (2018). Abstract CT131: A phase I study of adoptive immunotherapy for advanced ROR1+ malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR). Cancer Research. 78(13_Supplement). CT131–CT131. 17 indexed citations
15.
Specht, Jennifer M., Sylvia Lee, Cameron J. Turtle, et al.. (2018). Phase I study of immunotherapy for advanced ROR1+ malignancies with autologous ROR1-specific chimeric antigen receptor-modified (CAR)-T cells.. Journal of Clinical Oncology. 36(5_suppl). TPS79–TPS79. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026